Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy - Zaanan, A; Fléjou, J; Emile, J (Clinical cancer research: an official journal of the American Association for Cancer Research, 2011)
et al.